Systemic Mastocytosis with Associated Hematologic Neoplasm
📧 Sign up to get email alerts when something new happens for Systemic Mastocytosis with Associated Hematologic Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis [Phase 2]
Phase 2 PATHFINDER study evaluating avapritinib in advanced systemic mastocytosis and related subtypes has completed with results posted, as…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis [Phase 2]
Bezuclastinib is being studied in a Phase 2 trial for advanced systemic mastocytosis and related subtypes; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis
A clinical trial update on a patient-reported outcome questionnaire for systemic mastocytosis, with the study status marked as completed.